John L. Brottem insider trades
Open-market stock purchases and sales by John L. Brottem, General Counsel at Alamar Biosciences, Inc, from SEC Form 4 filings since May 26, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -85%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | ALMR Alamar Biosciences, Inc | Bought (not open market) | — |
| Sep 14, 2026 | ALMR Alamar Biosciences, Inc | Bought (not open market) | — |
| Aug 17, 2026 | OM Outset Medical, Inc | Sold | $11.6K |
| Jun 26, 2026 | OM Outset Medical, Inc | Bought (not open market) | — |
| May 15, 2026 | OM Outset Medical, Inc | Sold | $9.8K |
| Feb 17, 2026 | OM Outset Medical, Inc | Sold | $9.5K |
| Jan 21, 2026 | OM Outset Medical, Inc | Sold | $5.9K |
| Jan 20, 2026 | OM Outset Medical, Inc | Sold | $47.7K |
| Jan 7, 2026 | OM Outset Medical, Inc | Sold | $956 |
| Nov 17, 2025 | OM Outset Medical, Inc | Sold | $1.8K |